Status:
COMPLETED
Glucocorticoids, Immunotherapy and Radiosurgery for Brain Metastases
Lead Sponsor:
Medical University of Vienna
Conditions:
Brain Metastases
Eligibility:
All Genders
18-90 years
Brief Summary
Background. Brain metastases are the most common intracranial tumor and occur in 20-40% of all oncological patients. The most common primary cancer in brain metastases is lung cancer, followed by mela...
Eligibility Criteria
Inclusion
- Patients, who were treated with Gamma Knife Radiosurgery for at least one or more brain metastases and diagnosed with one of two most common primary cancers (lung cancer or melanoma)
- Patients over 18 years and under 90 years
- Written, signed informed consent for study particaption after study explanation
Exclusion
- Patients under 18 years
- Patients over 90 years
Key Trial Info
Start Date :
November 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 4 2024
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04042220
Start Date
November 1 2019
End Date
January 4 2024
Last Update
January 5 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Neurosurgery, Medical University of Vienna
Vienna, Austria, 1090